Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
September 8th, 2022 |
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
National Institutes of Health |
September 8th, 2022 |
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
September 8th, 2022 |
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
March 11th, 2020 |
Support Government of the Kingdom of Eswatini (GKoE) to Provide Comprehensive, Quality Assured Care, Treatment and Prevention HIV/TB Services to Achieve and Sustain Epidemic Control under the President's Emergency Plan |
Centers for Disease Control CGH |
February 19th, 2020 |
Improving HIV Prevention, Care and Treatment Outcomes Among Faith Communities in Zambia by Implementing Critical Prevention Interventions for HIV Risk Reduction, Case Finding, and Linkage to Care and Treatment for |
Centers for Disease Control CGH |
March 11th, 2020 |
Namibia Project for Information System Strengthening, Continuous Quality Improvement and Enhanced Surveillance to Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 10th, 2020 |
Strengthening of the Kingdom of Eswatini's Voluntary Medical Male Circumcision (VMMC) Program under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
September 1st, 2022 |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
August 14th, 2019 |
Liberia Community Health Activity |
Liberia USAID Monrovia |
November 12th, 2020 |
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) |
National Institutes of Health |
November 20th, 2019 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional) |
National Institutes of Health |
November 14th, 2019 |
US Children with Perinatal HIV who were Born Internationally (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2022 |
Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) |
National Institutes of Health |
October 3rd, 2022 |
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
October 19th, 2020 |
Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
December 3rd, 2019 |
Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed) |
National Institutes of Health |
November 20th, 2019 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
National Institutes of Health |
November 20th, 2019 |
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
National Institutes of Health |
September 7th, 2022 |
Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) |
National Institutes of Health |
September 3rd, 2019 |
The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional) |
National Institutes of Health |
|
February 11th, 2022 |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2020 |
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
August 9th, 2019 |
RFI-Local Partner Service Delivery Activity (LPSDA) - OVC Activities |
East Africa USAID Kenya |
June 28th, 2022 |
NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
August 9th, 2019 |
RFI -Local Partner Service Delivery Activity (LPSDA) - Integrated HIV Clinical and Orphaned and Vulnerable Children (OVC) Activities |
East Africa USAID Kenya |
August 9th, 2019 |
Local Partner Service Delivery Activity (LPSDA) - HIV Clinical, OVC, Family Planning, Reproductive Maternal Neonatal Child Adolescent Health (FP/RMNCAH) Activities |
East Africa USAID Kenya |
September 25th, 2019 |
FY 2020 RSVP Competition |
Corporation for National and Community Service |
July 30th, 2020 |
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) |
National Institutes of Health |
February 29th, 2020 |
American Schools and Hospitals Abroad Program Worldwide |
Agency for International Development |
November 21st, 2019 |
Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core Centers (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
November 21st, 2019 |
Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
September 1st, 2022 |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) |
National Institutes of Health |
September 6th, 2019 |
Household and Community Health and Health Systems Strengthening, Governance and Financing Activities |
Agency for International Development |
March 6th, 2020 |
Support to the Government of Botswana to Ensure Quality HIV-Related Strategic Information Services under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 28th, 2020 |
Improving Prevention, Treatment, and Care Services for HIV, TB, and Other Infectious Diseases in Target Populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 21st, 2020 |
HQ Supported Development, Implementation, Use and Evaluation of Interoperable Health Information Systems to Achieve HIV/AIDS and TB Epidemic Control through Improved Health Informatics Policy, Governance, Workforce |
Centers for Disease Control CGH |
September 10th, 2019 |
WIYIZIRE (Come here, we will support you) Health Activity |
Burundi USAID Bujumbura |
March 9th, 2020 |
Innovative, Comprehensive, Cost-effective and Locally Sustainable Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control in the Republic of Zimbabwe under the President's Emergency Plan |
Centers for Disease Control CGH |
November 15th, 2019 |
Network of Modeling Centers to Improve Evidence Base for Seasonal and Pandemic Influenza Prevention and Control |
Centers for Disease Control and Prevention ERA |
November 8th, 2019 |
Early Hearing Detection and Intervention National Technical Resource Center |
Health Resources and Services Administration |